Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



An Open-Label Phase Ib/II Study of Surufatinib in Combination with Tislelizumab in Subjects with Advanced Solid Tumors

Multiple Cancer Types

Miscellaneous, Phase I
I/II
Das, Satya
NCT04579757
VICCPHI20125

To learn more about any of our clinical
trials, call 615-936-8422.